The first clinical trial participants have received doses of the ChAdOx1 NipahB vaccine at the University of Oxford. Nipah virus is mostly found in South-East Asia that can be fatal in up to 75% of cases. Despite the first outbreaks occurring 25 years ago in… Read More
The University of Oxford has revealed that researchers are currently in the advanced stages of preparing for a clinical trial of a Nipah vaccine using the ChAdOx1 vector. The scientists are also working with partners to develop antivirals and monoclonals to treat those infected, according to… Read More
An early-stage clinical trial has been launched in the US investigating a vaccine against Nipah virus infection. The clinical trial has been launched by the National Institute of Allergy and Infectious Diseases (NIAID) to evaluate an investigational vaccine to prevent infection with Nipah virus. The virus is… Read More
